Skip to main content
Create Account
Training Center
Contact Us
Questions? Comments?
Contact us.
Email:
PLUS@pli.edu
Phone:
877.900.5291
PLI.edu
SIGN IN
Search
Browse
All Content
Books
- Answer Books
- Course Handbooks
- Journals
- Insights
- Treatises
Forms & Checklists
Transcripts
My Bookshelf
My History
< Back To Results
1 in 1 results
Previous Result
Next Result
Trial by Jury 2015
Chair(s):
David R. Marriott
Practice Area:
Criminal litigation,
Evidence,
Jury,
Jury selection,
Jury trials,
Litigation,
Trial
Published:
Nov 2015
i
Other versions can be found in the
Related Items
tab.
ISBN:
9781402425561
PLI Item #:
59043
CHB Spine #:
H1004
This version is not current.
Click here for the most recent version.
Search
Email
Print
Add To Bookshelf
Permalink
Table of Contents
Related Items
Select All
Front Matter
Faculty Bios
Table of Contents
Chapter 1. Jury Selection: Suggestions for Picking Your Triers of Fact
Chapter 2. Mastering Voir Dire and Jury Selection in the Age of Social Media
Chapter 3. Working with Trial Consultants
Chapter 4. Building Challenges “For Cause”: Practice Pointers for Improving Your Jury Pool
Chapter 5. Jury Questionnaire, United States District Court, Southern District of New York
Chapter 6. The Opening Statement: Charting a Path to Victory
Chapter 7. Opening Statement
Chapter 8. Storytelling in Legal Arguments
Chapter 9. Opening Statement: “Ten Points in Making an Effective Opening Statement”
Chapter 10. Plaintiff’s Opening Statement, Novartis International Pharmaceutical Ltd. v. Teva Pharmaceuticals, USA, Inc., U.S. District Court of New Jersey, 05-CV-1887-DMC (November 10, 2009)
Chapter 11. Direct to Success: How to Conduct an Effective Direct Examination
Chapter 12. Direct Examination: Making the Facts Understandable
Chapter 13. Redefining Credibility: Turning Expert Witnesses into Teachers
Chapter 14. Understanding is Believing: Teaching Science to Juries
Chapter 15. Direct Examination, Novartis International Pharmaceutical Ltd. v. Teva Pharmaceuticals, USA, Inc., U.S. District Court of New Jersey, 05-CV-1887-DMC (November 9, 2009)
Chapter 16. The Ethical Edge of Persuasive Tactics
Chapter 17. U.S. v. Parse, 13-1388-cr, United States Court of Appeals for the Second Circuit (June 8, 2015)
Chapter 18. U.S. v. Daugerdas, 867 F.Supp.2d 445 (June 4, 2012)
Chapter 19. Brief of Amicus Curiae, U.S. v. Parse, 13-1388-cr, United States Court of Appeals for the Second Circuit (November 13, 2013)
Chapter 20. Brief for Defendant Appellant David Parse, U.S. v. Parse, 13-1388-cr, United States Court of Appeals for the Second Circuit (November 6, 2013)
Chapter 21. Brief for the United States of America, U.S. v. Parse, 13-1388-cr, United States Court of Appeals for the Second Circuit (April 7, 2014)
Chapter 22. Cross Examination: Nine Suggestions for Success
Chapter 23. The Impressive Cross-Examination
Chapter 24. Cross-Examination of Expert Witnesses
Chapter 25. Cross-Examination, Apple Inc. v. Samsung Electronics Co., Ltd., United States District Court, Northern District of California, San Jose Division, C-11-01846 (August 3, 2012)
Chapter 26. Closing to Win, Closing Argument: Suggestions for Effective Advocacy
Chapter 27. Crafting a Successful Closing Argument
Chapter 28. In a Closing, Argue, Don’t Summarize (May 18, 2009)
Chapter 29. Preparing and Delivering the Defense Closing Argument
Chapter 30. Plaintiff’s Closing Argument, Novartis International Pharmaceutical Ltd. v. Teva Pharmaceuticals USA, Inc., U.S. District Court of New Jersey, 05-CV-1887-DMC (November 9, 2009)
Index
About Us